Bob Swift

Bear in Mind Podcast - Addiction: Understanding Substance Use Disorders with Robert Swift, MD PhD

Robert Swift, MD PhD recently joined Bear in Mind, the Brown Psychiatry Podcast, for part 1 of a discussion on substance use disorders.

Listen to the conversation

Molly Magill

Manuscript Considers Intersection of Mechanisms of Behavior Change Science and Implementation Science

CAAS's Dr. Molly Magill and other members of the Mechanisms of Behavior Change Satellite Meeting Committee recently published Addictions treatment mechanisms of change science and implementation science: A critical review in Alcoholism: Clinical and Experimental Research.

young people in group

Drs Pielech, Miranda Publish Policy Position Statement Regarding Allocation of Opioid Settlement Funds

Drs Melissa Pielech and Robert Miranda, in conjunction with co-authors and the Society of Behavioral Medicine, published a policy position statement advocating for allocating funds from opioid settlement lawsuits towards expansion of youth substance use treatment.

Dr. Jasjit Ahluwalia

Dr. Ahluwalia to Receive Health Equity SIG Lifetime Achievement Award

Dr. Jasjit S. Ahluwalia has been awarded the 2023 Health Equity SIG Lifetime Achievement Award, which will be presented at the Society of Behavioral Medicine's annual scientific meeting in Phoenix, Arizona.

ANAC logo

Cioe, Camacho Present at Annual Association of Nurses in AIDS Care

Dr. Patricia Cioe and Bianca Camacho, student Research Assistant and Brown University graduate '21, presented a paper presentation at the Annual Association of Nurses in AIDS Care on November 18, 2022 in Tampa FL.

Dr. David Zelaya

David Zelaya Appointed to APA Committee on Ethnic Minority Affairs

David G. Zelaya was appointed to serve on the American Psychological Association's Committee on Ethnic Minority Affairs (CEMA).

MDMA crystals

CAAS to Conduct its First Pilot Trial of Psychedelics

Drs. Christy Capone, Erica Eaton, and Carolina Haass-Koffler have received funding from the OVPR and the CADRE to conduct the first pilot trial of psychedelics at CAAS, under a grant entitled "Safety, feasibility, and acceptability of MDMA-assisted therapy for the treatment of co-occurring alcohol use disorders and posttraumatic stress disorder in veterans."